Moin Makda: HemeNext Felt Like a Full Circle Moment
Moin Makda, Student Intern at Fortis Healthcare, shared on LinkedIn:
”HemeNext felt like a full circle moment.
Eight months ago, I was on Figma, designing screens for a post-BMT app.
Just wireframes, hope and a pitch deck for the IHH Sandbox Grant that we wasn’t even sure would get selected.
We got the grant. Then we got obsessed.
Fast forward to last Sunday, watching Swarsat K. Nath present JIVANA AI at HemeNext, in front of clinicians and innovators who actually get what we’re trying to build.
That’s when it hit me. We’ve come a long way from those Figma frames.
One app became six solutions. One late night became a hundred.
Marrowlogue, ThalSaarthi, CuraScript, AI Caller, ReLit, Jivana Research – each one born from a real problem we saw in real clinics.
ThalSaarthi won the Catalyst Innovation Grant and Second Prize at DoctorsAI Global Summit.
Abstracts got accepted. Grants kept coming. Strangers became collaborators.
But here’s the thing, none of this happens in a vacuum.
Dr. Rahul Bhargava and Shrinidhi Nathany didn’t just support us, they believed in us when we were still figuring things out.
They pushed us to think beyond the obvious, to build things that actually solve real problems in real clinics.
Sumit Wadhwa kept us grounded when we got too lost in the tech. Yashpal Singh Rawat and Dr Ritu Mittal Garg gave us the infrastructure to actually build, not just dream.
And Swarsat K. Nath? Man, watching him present at HemeNext and explaining to a room full of hematologists who’ve spent their lives in this field, I realized how far we’ve both come.
From “let’s try this” to “this is actually working.”
HemeNext itself was something special.
Dr Vikas Dua, the entire team at Fortis Healthcare, Gurgaon Dr Ritu Mittal Garg, Tabish Jamshed, Parishmita Chabukdhara, Naveen Uppal, Sidarth Verma, Vani Sharma, Suparna Paul, Aastha Gupta, Swati Bhayana, Dr. Neha Rastogi Panda, Rachit Agrawal made it more than a conference.
They made it a movement.
Somewhere between the code reviews and the clinician feedback sessions, we stopped just building healthcare tech.
We started building something that might actually matter.
I’m not saying we’ve made it, we’re still figuring out half of this as we go.
But standing at HemeNext, seeing our work out there in the real world, with real doctors having real conversations about it.. that Figma file feels like a lifetime ago.
Here’s to the next and many more eight months.
And to everyone who took a chance to make healthcare a little less broken.
If you told me last March that I’d be here, I wouldn’t have believed you.
But I’m really glad I didn’t stop at wireframes.”
Stay updated with Hemostasis Today.
-
Mar 12, 2026, 20:44Honoring Marion Stolte’s Lasting Impact on the Bleeding Disorders Community – WFH
-
Mar 12, 2026, 20:37Paul Riley: Is Thrombin Generation Assay Ready for Prime Time?
-
Mar 12, 2026, 20:28Rob Maloney: Building Visibility for Bleeding Disorders in Rural Georgia
-
Mar 12, 2026, 20:19Akshat Jain: Validating Oral Pain Medication Use as a Global Marker in Sickle Cell Disease
-
Mar 12, 2026, 20:13Michael Makris: Early Clinical Results of AAV8-BDD FVIII Gene Therapy in Hemophilia A
-
Mar 12, 2026, 20:02Wolfgang Miesbach: From Heparin to Vaccines – The Expanding Biology of Anti-PF4 Immunothrombosis
-
Mar 12, 2026, 19:56Christophe Dubois: Celebrating Nicolas Gendron’s HDR Defense and Future in Hemostasis
-
Mar 12, 2026, 17:06Caitlin Raymond: Managing Crigler–Najjar Syndrome Type 1 Crisis Without a Standard TPE Protocol
-
Mar 12, 2026, 17:03Jan Sloves: Insights on Comprehensive Venous Duplex Imaging at VEITH Symposium 2025